Drimva

HeartFlow

Principal Clinical Engineer – AI Performance & Investigations

$188K–$240K

San Francisco, California +1 · Principal · Full-time · Posted Oct 16, 2026

Location
San Francisco, California
San Francisco
Experience
12+ years; no alternatives stated.
Education
B.S. or M.S. in Biomedical Engineering, Electrical Engineering, Computer Science, Physics, or a related technical or clinical discipline; advanced degree preferred.

About the job

Leads complex, escalated technical investigations of HeartFlow’s AI/ML coronary imaging products, determining root causes and translating findings into regulatory decisions and product improvements.

What you'll do

  • Investigate product complaints and anomalies by analyzing case evidence, reproducing issues, and documenting root causes and corrective actions.
  • Partner with engineering, clinical, quality, and regulatory teams to assess patient impact, identify trends, and support reportability, CAPA, risk, and field-action decisions.
  • Improve investigation methods, mentor investigators, and feed findings back to product development.

What they ask for

  • 12+ years of experience in medical devices and/or regulated imaging products, including substantial engineering, investigation, or post-market quality experience.
  • Hands-on coronary CT experience, such as CCTA, coronary plaque characterization, or atherosclerosis imaging.
  • Demonstrated leadership of complex cross-functional technical investigations through root cause and documented conclusion.
  • Working knowledge of complaint handling, MDR/vigilance, CAPA, risk management, and software/SaMD investigation requirements.

Nice to have

  • Advanced degree (e.g., Ph.D. or clinical degree).
  • Experience with cardiovascular imaging, FFR/FFRct, quantitative plaque analysis, AI/ML medical-device performance, invasive reference standards, or health hazard evaluations and field actions.

Pay

$188,000 to $240,000 per year (USD, base salary)

Tools

CCTA, FFRct, AI/ML, SaMD, FDA MDR (21 CFR Part 803), FDA QMSR (21 CFR Part 820), ISO 13485, ISO 14971

AI focus

Investigates performance and anomalies in AI/ML-enabled coronary artery disease products and evaluates AI-assisted investigation approaches.

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 5, 2026 (UTC)